Italia markets open in 6 hours 36 minutes

Dow Jones
39.869,38
-38,62(-0,10%)
Nasdaq
16.698,32
-44,07(-0,26%)
Nikkei 225
38.631,45
-288,81(-0,74%)
EUR/USD
1,0865
-0,0005(-0,04%)
Bitcoin EUR
60.239,36
-841,56(-1,38%)
CMC Crypto 200
1.374,60
-19,44(-1,40%)

NBIX May 2024 135.000 call

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

5,36

-0,79

(-12,85%)

In data: 02:27PM EDT. Mercato aperto.

GlobeNewswire
Sosei Heptares’ partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of NBI-1117570 in Healthy Adults
NBI-1117570 is an investigational, oral, muscarinic M1/M4 selective dual agonist discovered by Sosei Heptares that may have the potential to treat neurological and neuropsychiatric conditionsNBI-1117570 is the second compound to advance into clinical development from a portfolio of selective muscarinic receptor agonists licensed by Sosei Heptares to Neurocrine following NBI-1117568, an oral, selective muscarinic M4 receptor agonist, which is in Phase 2 clinical trials as an investigational treat